Pheochromocytomas/paragangliomas are characterized by a unique molecular landscape
that allows their assignment to clusters based on underlying genetic alterations. With around …

A molecular biology–based taxonomy has been proposed for pheochromocytoma and
paraganglioma (PPGL). Data from the Cancer Genome Atlas revealed clinically relevant …

Paragangliomas and phaeochromocytomas are neuroendocrine tumours whose
pathogenesis and progression are very strongly influenced by genetics. A germline mutation …

Paragangliomas and pheochromocytomas (PPGL) are rare neuroendocrine tumours
characterized by a strong genetic determinism. Over the past 20 years, evolution of PPGL …

Phaeochromocytomas and paragangliomas (PPGLs) are neural-crest-derived tumours of
the sympathetic or parasympathetic nervous system that are often inherited and are …

Paragangliomas are neuroendocrine neoplasms, derived from paraganglia of the
sympathetic and parasympathetic nervous systems. They are most commonly identified in …

Importance Effective cancer prevention is based on accurate molecular diagnosis and
results of genetic family screening, genotype-informed risk assessment, and tailored …

Pheochromocytoma and paraganglioma (PPGL) can be divided into at least four molecular
subgroups. Whether such categorizations are independent factors for prognosis or …

Pheochromocytoma and paraganglioma (PPGL) are rare tumours and at least 30% are part
of hereditary syndromes. Approximately 20% of hereditary PPGL are caused by pathogenic …

Pheochromocytomas and paragangliomas (PCC/PGL) are the solid tumour type most
commonly associated with an inherited susceptibility syndrome. However, very little is …